Stanozolol USP29, Ph.Eur.5.5, Micronized grade
Molecular Formula: C22H36N2O
Molecular Weight: 344.53 gm/mol
Active life: 8 hours
Detection Time: 3 weeks
Anabolic/Androgenic Ratio (Range): 320:30
Stanozolol®, brand of Stanozolol tablets, is an anabolic steroid, a synthetic derivative of testosterone. Each tablet contains 50 mg and 100 mg of Stanozolol USP29, Ph.Eur.5.5, micronized grade. It is designated chemically as 17-methyl-2'H -5ฮฑ-androst-2eno[3,2-c]pyrazol-17ฮฒ-ol.
Each tablet also contains lactose monohydrate, sodium starch glycolate, polyvidone 25,000, microcrystalline cellulose and magnesium stearate as excipients. The 50 mg tablet also contains yellow ferric oxide (E172) and indigo carmine aluminium lake (E132) as colouring agent and the 10 mg tablet also contains yellow ferric oxide (E172)
Stanozolol® is an oral androgen derived from dihydrotestosterone. Stanozolol® acts on androgen receptors to promote anabolism through increased nitrogen retention and protein synthesis in muscle tissue. Stanozolol® is a strong anabolic substance with androgenic action. Stanozolol does not convert to estrogen and therefore does not produce typical estrogen mediated side effects such as water retention. Stanozolol has a large oral bioavailability, due to a C17 a-alkylation which allows the hormone to survive first pass liver metabolism. Stanozolol reduces SHBG increasing free testosterone levels.